Discover
KOD
Kodiak Sciences Inc.
32.04
2 x 30.95
2 x 55.16
bid
ask
-
0.67
2.05%
01:17 PM
timesize
| Ytd | 14.59% | |
| 1y | 236.20% |
32.00
day range
33.34
9.80
52 week range
47.84
| Open | 33.04 | Prev Close | 32.71 | Low | 32.00 | High | 33.34 | Mkt Cap | 2.01B |
| Vol | 269.81K | Avg Vol | 688.47K | EPS | -4.19 | P/E | N/A | Forward P/E | -8.73 |
| Beta | 2.18 | Short Ratio | 18.37 | Inst. Own | 102.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 39.37 | 200-d Avg | 33.67 | 1yr Est | 69.60 |
| Income Statement | |||
| Operating Expenses | 66.84M | ||
| Research and Development Expense | 56.08M | ||
| Selling, General and Administrative Expense | 10.76M | ||
| Operating Income | -66.84M | ||
| Net Income | -65.64M | ||
| Net Income Common Stock | -65.64M | ||
| Net Income Common Stock (USD) | -65.64M | ||
| Consolidated Income | -65.64M | ||
| Earnings per Basic Share | -1.05 | ||
| Earnings per Basic Share (USD) | -1.05 | ||
| Earnings per Diluted Share | -1.05 | ||
| Earning Before Interest & Taxes (EBIT) | -65.64M | ||
| Earning Before Interest & Taxes (USD) | -65.64M | ||
| Weighted Average Shares | 62.63M | ||
| Weighted Average Shares Diluted | 62.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 132.09M | ||
| Cash and Equivalents (USD) | 132.09M | ||
| Current Assets | 131.36M | ||
| Property, Plant & Equipment Net | 110.61M | ||
| Total Assets | 256.81M | ||
| Debt Current | 9.81M | ||
| Total Debt | 152.76M | ||
| Current Liabilities | 52.77M | ||
| Debt Non-Current | 142.95M | ||
| Total Liabilities | 195.72M | ||
| Accumulated Retained Earnings (Deficit) | -1.68B | ||
| Shareholders Equity | 61.10M | ||
| Shareholders Equity (USD) | 61.10M | ||
| Assets Non-Current | 125.45M | ||
| Total Debt (USD) | 152.76M | ||
| Liabilities Non-Current | 142.95M | ||
| Trade and Non-Trade Payables | 12.64M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.19M | ||
| Net Cash Flow from Financing | 2.96M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -43.63M | ||
| Capital Expenditure | -352.00K | ||
| Issuance (Purchase) of Equity Shares | 2.96M | ||
| Net Cash Flow from Investing | -352.00K | ||
| Net Cash Flow from Operations | -46.24M | ||
| Share Based Compensation | 11.61M | ||